TY - JOUR T1 - Point-of-care HbA1c Measurements in Oral Cancer and Control Patients in Hungary JF - In Vivo JO - In Vivo SP - 2248 LP - 2254 DO - 10.21873/invivo.12952 VL - 36 IS - 5 AU - ADAM VEGH AU - DANIEL VEGH AU - DOROTTYA BANYAI AU - GABOR KAMMERHOFER AU - ZITA BICZO AU - BALAZS VOROS AU - MARTA UJPAL AU - JUAN FRANCISCO PEÑA-CARDELLES AU - ZEHRA YONEL AU - ARPAD JOOB-FANCSALY AU - PETER HERMANN AU - ZSOLT NEMETH Y1 - 2022/09/01 UR - http://iv.iiarjournals.org/content/36/5/2248.abstract N2 - Background/Aim: This study aimed to investigate the link between preoperative glycated hemoglobin (HbA1c) levels and oral cancer patients and diabetes mellitus (DM). We aimed to highlight the importance of point-of-care HbA1c measurements in oral cancer patients. Patients and Methods: A total of 214 patients were admitted to the Department of Inpatient Care at Semmelweis University’s Department of Oromaxillofacial Surgery and Stomatology between 1 September 2020 and 21 May 2021; individuals, who had undergone maxillofacial surgery under general anesthesia, were included in the study. Results: There was a significant difference between the oral cancer group and the control group in terms of smoking (p=0.009) and alcohol intake (p=0.003). There was no statistically significant difference regarding sex (p=0.132) and DM (p=0.147) between the two groups. The tumor group had an 8.52% greater prevalence of DM, which was not significant. In the oral cancer group, twenty individuals (17.69%) had a higher HbA1c level than the upper level of the optimal metabolic value (6.9%). Nine participants (8.91%) in the control group had an HbA1c value greater than 6.9%, which means that their metabolic level was poor. The oral cancer group did not have higher blood glucose levels than those of the control group. Conclusion: No direct connection between high blood glucose levels and oral cancer was found. However, point-of-care HbA1c measurement can be a diagnostic tool to detect DM in the dental office. ER -